leisure time -WSS

leisure time

author：leisure time 2025-09-27 10:01:38 - browse：3

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Another man arrested in connection with shooting at Kansas nightclub

hotspot

WSS

UPS workers' union leader explains what's at stake as strike edges closer

Startling documents reveal new facets of Sacklers' opioid empire

Average age of first period drops to 11.9 years, study shows

Drinking water from half of US faucets contains PFAS: Study

Scientists successfully use ultrasound imaging to map brain activity

North Korean leader's powerful sister says warplanes repelled US spy plane

knowledge

leisure time

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Duchenne breakthrough therapy leaves behind pioneering families

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

What does generative AI mean for health care? We asked experts

Drinking water from half of US faucets contains PFAS: Study

Medicare details structure of new drug price negotiation program

Health insurers say they are turning to AI to cut costs, improve care

explore

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Why Titanic fascinates society, still drawing tours to the wreckage

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

What to know about a major upcoming Wegovy heart health study

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

leisure time

hotspot

knowledge

knowledge